NCT04294550View on ClinicalTrials.gov

Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions

Opioid UseConstipation Drug InducedCancer

Interventions

OTHER

Naloxegol

28 days of therapy with 25 mg/day of Naloxegol on cancer patients using opioids and suffering for opioids induced constipation not relieved by first-line laxatives.

Trial Locations (1)

40128

Fondazione ANT Italia ONLUS, Bologna

All Listed Sponsors

lead

Fondazione ANT Italia ONLUS

OTHER

NCT04294550 - Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol | Biotech Hunter | Biotech Hunter